Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department Of Translational Genomics |
RCV000171367 | SCV000221564 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
Invitae | RCV000171367 | SCV002235308 | pathogenic | not provided | 2022-06-13 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 191181). This premature translational stop signal has been observed in individual(s) with autosomal recessive retinitis pigmentosa (PMID: 24876279, 25999674). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Tyr171*) in the IMPG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IMPG2 are known to be pathogenic (PMID: 20673862). |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000678577 | SCV000804659 | pathogenic | Vitelliform macular dystrophy 5 | 2016-09-01 | no assertion criteria provided | clinical testing | |
Faculty of Health Sciences, |
RCV001257828 | SCV001434691 | pathogenic | Autosomal recessive retinitis pigmentosa | 2015-09-10 | no assertion criteria provided | literature only |